Imiquimod 3.75% Cream

DRUG2 trials

Sponsors

Icahn School of Medicine at Mount Sinai, Medical University of Graz

Conditions

Actinic KeratosesActinic Keratosis

Phase 2

Genomic Markers Before and After Treatment of Actinic Keratosis With Imiquimod 3.75% Cream

CompletedNCT03914417

Icahn School of Medicine at Mount SinaiActinic Keratosis

Start: 2013-01-31End: 2015-04-30Updated: 2021-01-20

Phase 4

Earliest Stage Treatment of Aktinic Keratosis With Imiquimod 3.75% Cream

CompletedNCT04842422

Medical University of GrazActinic Keratoses

Start: 2021-04-16End: 2021-08-23Updated: 2022-01-11